Kimia Therapeutics Advances Oncology Asset to Clinical Stage

Kimia Therapeutics advanced an oncology drug candidate into a clinical stage in collaboration with CStone Pharmaceuticals. The candidate targets pathways critical for tumor cell survival; the body does not specify the phase number.